ReShape Lifesciences RSLS
8.39
0.23
2.67
%
已收盤:01/21 21:00 (臺灣)
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
---|---|---|---|---|---|---|
2024Q3 | 5.65 | 111.87 | -2.66 | -1,762 | -2 | |
2024Q2 | 11.11 | 130.66 | -4.06 | -2,054 | -2 | |
2024Q1 | 10.70 | 101.01 | -5.22 | -2,210 | -2 | |
2023Q4 | 14.48 | 111.93 | 89.19 | -1,895 | -2 | |
2023Q3 | 19.60 | 109.88 | -56.13 | -3,880 | -4 | |
2023Q2 | 85.84 | 114.91 | -53.36 | -3,977 | -3 | |
2023Q1 | 149.06 | 213.05 | -90.49 | -5,631 | -3 | |
2022Q4 | 390.93 | 100.82 | -2036.54 | -16,693 | -16 | |
2022Q3 | 870.89 | 97.66 | -1590.49 | -12,346 | -12 | |
2022Q2 | 1672.76 | 94.27 | -1421.11 | -9,662 | -10 | |
2022Q1 | 3422.08 | 100.32 | -1268.56 | -8,400 | -8 | |
2021Q4 | 4756.10 | 99.99 | -7857.43 | -35,557 | -35 | |
2021Q3 | 8352.18 | -2900.06 | -14,984 | -18 | ||
2021Q2 | 14500.32 | -2407.05 | -3,702 | -4 | ||
2021Q1 | 53.11 | -3596.08 | -2,257 | -5 | ||
2020Q4 | 39.11 | -6322.14 | -3,204 | -9 | ||
2020Q3 | 48.50 | -6409.14 | -2,173 | -5 | ||
2020Q2 | 104.68 | 2581.06 | -2,999 | -4 | ||
2020Q1 | 96.59 | -5916.13 | -4,081 | -4 | ||
2019Q4 | 12.07 | 348.01 | -3,114 | -25 |